Skip to main content
. 2015 Dec 2;10(12):e0143103. doi: 10.1371/journal.pone.0143103

Fig 4. T-Tau (Mab DA31) and P-Tau (Mabs RZ3 and PHF1) levels in normal (controls 1–5) and sCJD (sCJD 1–5) brains measured by EIMAF.

Fig 4

Values are expressed as mean ± SD. Significance between T-Tau vs. P-Tau in control samples (*p < 0.05) and between T-Tau levels in control vs. sCJD (**p < 0.01) is determined by the unpaired t-test.